Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug

Clinical trial NCT00478595 · TERMINATED

Trial details

NCT number: NCT00478595
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Diabetes Mellitus Type 2

Start date: 2007-04-01
Primary completion: 2009-02-01
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.